June 25th, 2024: Research shows increased aspiration pneumonia risk for GLP-1 users during procedures Recent research highlights a significant concern for users of glucagon-like peptide-1 receptor agonists (GLP-1RAs), commonly prescribed for diabetes management
Separately, radiographic imaging out of Vanderbilt University Medical Center has quantified how much midface volume is lost per kilogram and where it goes from
Over up to seven years of follow-up, those treated with semaglutide or tirzepatide had a 37% lower risk of developing dementia (hazard ratio [HR] 0.63, 95% CI 0.500.81), a 19% lower risk of stroke (HR 0.81, 95% CI 0.700.93), and a 30% lower risk of all-cause mortality (HR 0.70, 95% CI 0.630.78), compared to those on other antidiabetic drugs
An informed patient community is forming, and regulatory agencies are reviewing claims and safety data
More than 100 new cases were added in early February
Seek urgent medical care if you develop severe abdominal pain, persistent vomiting, or an inability to pass gas ., Why do tirzepatide and semaglutide cause constipation
